Endocrine effects and pharmacokinetic characteristics of a potent new gonadotropin-releasing hormone antagonist (Ganirelix) with minimal histamine-releasing properties: studies in postmenopausal women-Reference-Cited by-同舟云学术

Endocrine effects and pharmacokinetic characteristics of a potent new gonadotropin-releasing hormone antagonist (Ganirelix) with minimal histamine-releasing properties: studies in postmenopausal women

Published:1992-11-01 Issue:5 Volume:75 Page:1220-1225
ISSN:0021-972X
Container-title:Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:Journal of Clinical Endocrinology & Metabolism

Author:

Rabinovici J.

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cumulative live birth rate of in vitro fertilization cycle via progestin-primed ovarian stimulation versus gonadotropin-releasing hormone antagonist protocol in infertile women with normal ovarian reserve: an open-label, randomized controlled trial;Human Fertility;2024-02-15

2. Therapeutic effects of an oral gonadotropin‐releasing hormone receptor antagonist, relugolix, on preventing premature ovulation in mild ovarian stimulation for IVF;Reproductive Medicine and Biology;2021-10-19

3. Dynamic Interactions Between LH and Testosterone in Healthy Community-Dwelling Men: Impact of Age and Body Composition;The Journal of Clinical Endocrinology & Metabolism;2019-12-02

4. Agonist Versus Antagonist in Intracytoplasmic Sperm Injection Cycles: Which Is the Best?;International Journal of Women's Health and Reproduction Sciences;2019-10-01

5. Comparison of GnRH Agonist, GnRH Antagonist, and GnRH Antagonist Mild Protocol of Controlled Ovarian Hyperstimulation in Good Prognosis Patients;International Journal of Endocrinology;2015